Toggle Offcanvas
...
 
Tocilizumab Tenders

Tocilizumab Tenders

View Tocilizumab tenders, RFPs and contracts. Bid on readily available Tocilizumab tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Tocilizumab tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Tocilizumab.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Tocilizumab market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Tocilizumab tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

34 Live Notices for Tocilizumab Tenders

Showing 1 to 20

Supply of Medicine and Medical / Surgical equipments : Tocilizumab Concentrate Solution for etc .
country Sri Lanka
posting date13 Mar 2025
deadline23 Apr 2025
Price Registration For Tocilizumab Medicine Supply 6 Mg/Kg According To Court Decision No. 0000033-75.2025.8.26.0434 *
country Brazil
posting date11 Mar 2025
deadline26 Mar 2025
Tocilizumab 80 Mg/4Ml 003
country Saudi Arabia
posting date06 Mar 2025
deadline22 Mar 2025
Object: Electronic Auction - Price Registration For Medicines Acquisition - Perp 002/2025
country Brazil
posting date01 Mar 2025
deadline15 Mar 2025
Oncological And General Drugs
country Poland
posting date28 Feb 2025
deadline01 Apr 2025
Tocilizumab, 20Mg/Ml, 10M Ampoule Bottle - 60 Units
country Brazil
posting date27 Feb 2025
deadline14 Mar 2025
Medicines For The Treatment Of Rare Diseases In The Republic Of North Macedonia For 2025
country North Macedonia
posting date18 Feb 2025
deadline17 Mar 2025
Purchase And Delivery Of Biological Medicines
country Poland
posting date12 Feb 2025
deadline19 Mar 2025
Drugs For Biological Therapy 2025
country Slovakia
posting date11 Feb 2025
deadline17 Mar 2025
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia
country Spain
posting date30 Dec 2024
deadline01 Oct 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Tocilizumab (Atc Code According To Who: L04Ac07)
country Germany
posting date11 Nov 2024
deadline31 Dec 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Tocilizumab (Atc Code According To Who: L04Ac07)
country Germany
posting date11 Nov 2024
deadline31 Dec 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Tocilizumab (Atc Code According To Who: L04Ac07)
country Germany
posting date11 Nov 2024
deadline31 Dec 2025
Open House Award 2024-4
country Germany
posting date22 Oct 2024
deadline30 Nov 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Tocilizumab (Excl. Infusion Solution Concentrate), Atc L04Ac07 (Obo) For The Period 01.10.2024 - 30.11.2025
country Germany
posting date19 Aug 2024
deadline05 Oct 2025
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab
country Germany
posting date22 May 2024
deadline11 May 2026
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab
country Germany
posting date22 May 2024
deadline11 May 2026
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab
country Germany
posting date21 May 2024
deadline11 May 2026
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tocilizumab, Atc L04Ac07 For The Period December 1St, 2023 - November 30Th, 2024 (Plus Extension Option 1X12 Months)
country Germany
posting date20 Oct 2023
deadline05 Oct 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Tocilizumab (L04Ac07) As Part Of A So-Called Open House Model.
country Germany
posting date11 Oct 2023
deadline30 Sep 2025

Share Share this page